Invesco Nasdaq Biotechnology ETF
Registrant
Invesco Exchange-Traded Fund Trust II
Class ticker
Net Assets
$67,373,541
Holdings
252
Latest Report
May 31, 2026
Net Assets Over Time
Holdings · 252
Export CSV
Showing 1–50
of 252 holdings by value
· page 1 of 6
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | GILD | 37,039 | $4,979,153 | 7.39% | Long | EC | |
| Vertex Pharmaceuticals Inc. | VRTX | 11,104 | $4,969,484 | 7.38% | Long | EC | |
| Amgen Inc. | AMGN | 14,213 | $4,786,796 | 7.10% | Long | EC | |
| Regeneron Pharmaceuticals, Inc. | REGN | 5,570 | $3,424,325 | 5.08% | Long | EC | |
| Alnylam Pharmaceuticals, Inc. | ALNY | 7,110 | $2,147,078 | 3.19% | Long | EC | |
| Revolution Medicines, Inc. | RVMD | 10,624 | $1,673,068 | 2.48% | Long | EC | |
| Biogen Inc. | BIIB | 7,868 | $1,542,128 | 2.29% | Long | EC | |
| Illumina, Inc. | ILMN | 8,197 | $1,335,783 | 1.98% | Long | EC | |
| United Therapeutics Corp. | UTHR | 2,350 | $1,308,527 | 1.94% | Long | EC | |
| Royalty Pharma PLC | RPRX | 22,968 | $1,280,696 | 1.90% | Long | EC | |
| argenx SE | ARGX | 1,521 | $1,271,541 | 1.89% | Long | EC | |
| Insmed Inc. | INSM | 11,556 | $1,235,452 | 1.83% | Long | EC | |
| Roivant Sciences Ltd. | ROIV | 38,370 | $1,150,716 | 1.71% | Long | EC | |
| Incyte Corp. | INCY | 10,669 | $1,032,119 | 1.53% | Long | EC | |
| Viatris Inc. | VTRS | 61,728 | $1,003,697 | 1.49% | Long | EC | |
| Moderna, Inc. | MRNA | 21,173 | $999,154 | 1.48% | Long | EC | |
| Guardant Health, Inc. | GH | 7,032 | $911,980 | 1.35% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 5,381 | $851,812 | 1.26% | Long | EC | |
| Jazz Pharmaceuticals PLC | JAZZ | 3,300 | $780,417 | 1.16% | Long | EC | |
| Ascendis Pharma A/S | ASND | 3,301 | $739,787 | 1.10% | Long | EC | |
| Summit Therapeutics Inc. | SMMT | 41,569 | $729,120 | 1.08% | Long | EC | |
| Exelixis, Inc. | EXEL | 13,923 | $702,833 | 1.04% | Long | EC | |
| BridgeBio Pharma, Inc. | BBIO | 10,393 | $688,640 | 1.02% | Long | EC | |
| Medpace Holdings, Inc. | MEDP | 1,522 | $680,501 | 1.01% | Long | EC | |
| Ionis Pharmaceuticals, Inc. | IONS | 8,856 | $677,484 | 1.01% | Long | EC | |
| Axsome Therapeutics, Inc. | AXSM | 2,742 | $642,944 | 0.95% | Long | EC | |
| Madrigal Pharmaceuticals, Inc. | MDGL | 1,230 | $611,642 | 0.91% | Long | EC | |
| BioMarin Pharmaceutical Inc. | BMRN | 10,311 | $590,717 | 0.88% | Long | EC | |
| BioNTech SE | BNTX | 6,112 | $586,446 | 0.87% | Long | EC | |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 7,507 | $584,870 | 0.87% | Long | EC | |
| Sanofi | SNY | 13,122 | $573,038 | 0.85% | Long | EC | |
| Praxis Precision Medicines, Inc. | PRAX | 1,493 | $522,505 | 0.78% | Long | EC | |
| Cytokinetics, Inc. | CYTK | 6,597 | $506,386 | 0.75% | Long | EC | |
| BeOne Medicines Ltd. | ONC | 1,714 | $493,495 | 0.73% | Long | EC | |
| Krystal Biotech, Inc. | KRYS | 1,567 | $484,250 | 0.72% | Long | EC | |
| Tempus AI, Inc. | TEM | 9,314 | $470,078 | 0.70% | Long | EC | |
| Abivax S.A. | ABVX | 3,294 | $436,883 | 0.65% | Long | EC | |
|
Nuvalent, Inc.
|
670703107 | 3,923 | $433,060 | 0.64% | Long | EC | |
| Halozyme Therapeutics, Inc. | HALO | 6,327 | $420,999 | 0.62% | Long | EC | |
| ImmunityBio, Inc. | IBRX | 55,119 | $414,495 | 0.62% | Long | EC | |
| Vaxcyte, Inc. | PCVX | 7,716 | $396,602 | 0.59% | Long | EC | |
| Alkermes PLC | ALKS | 8,934 | $376,925 | 0.56% | Long | EC | |
| Immunovant, Inc. | IMVT | 10,912 | $363,370 | 0.54% | Long | EC | |
| Kymera Therapeutics, Inc. | KYMR | 4,377 | $356,375 | 0.53% | Long | EC | |
| Protagonist Therapeutics, Inc. | PTGX | 3,421 | $340,595 | 0.51% | Long | EC | |
| Mirum Pharmaceuticals, Inc. | MIRM | 3,235 | $328,353 | 0.49% | Long | EC | |
| PTC Therapeutics, Inc. | PTCT | 4,433 | $327,377 | 0.49% | Long | EC | |
| Rhythm Pharmaceuticals, Inc. | RYTM | 3,661 | $323,340 | 0.48% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 4,207 | $309,215 | 0.46% | Long | EC | |
| Cogent Biosciences, Inc. | COGT | 8,702 | $304,222 | 0.45% | Long | EC |